NCT02085148 2024-04-22
A Phase I Dose Finding Study in Children With Solid Tumors Recurrent or Refractory to Standard Therapy
Bayer
Phase 1 Completed
Bayer
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Children's Oncology Group